Overview
Compare with Baldwin Insurance Group, Inc., CRAWFORD & CO or CorVel Corporation, or pick any stock.
- TickerSLQT on NYSE1
- IndustryInsurance Agents, Brokers & Service1
- HeadquartersOverland Park, Kansas1
- Incorporated inDE3
- Business address6800 West 115Th Street, Suite 2511, Overland Park, Ks 662113
- Filer categoryAccelerated filer, Smaller reporting company3
See how the biggest companies compare on our leaderboards
SelectQuote, Inc. (together with its subsidiaries, “SelectQuote”, the “Company”, “we”, “us”) is a leading technology-enabled, direct-to-consumer (“DTC”) distribution and engagement platform for selling insurance policies and healthcare services.5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
4.6%Operating margin2
3.8%Net margin2
6.0%Revenue growth, 20262
17.7%Return on equity2
0.99×Debt to equity2
$27.6MFree cash flow2
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Pharmacy brought in 51% of the revenue SelectQuote, Inc. broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Pharmacy | $464.9M | $728.8M | $830.9M |
| Service | $856.9M | $797.8M | $787.6M |
Business segments
Healthcare Services brought in 52% of the revenue SelectQuote, Inc. broke down this way in fiscal 2026.
Business segments by year
| Business segments | 2024 | 2025 | 2026 |
|---|---|---|---|
| Healthcare Services | $478.5M | $742.7M | $844.9M |
| Senior | $655.8M | $600.4M | $575.9M |
| Life | $157.9M | $173.0M | $186.0M |
| All Other Revenue | $36.2M | $18.0M | $20.2M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue45¢$730.7M
- Selling, general and admin9¢$149.0M
- Other costs38¢$617.9M
- Interest3¢$44.5M
- Income tax1¢$14.1M
- Profit4¢$62.2M
Out of $1.6B in revenue.2
Where each dollar of operating cash went, fiscal 2026
- Capital spending13¢$4.3M
- Kept or used elsewhere87¢$27.6M
Out of $31.9M of cash from operations.2
Financial statements
Every line of the income statement as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Total revenue | $1.6B | $1.5B | $1.3B |
| Cost of commissions and other services revenue | $312.2M | $305.1M | $318.8M |
| Cost of goods soldpharmacy revenue | $730.7M | $630.3M | $405.0M |
| Marketing and advertising | $313.7M | $319.5M | $358.9M |
| Selling, general, and administrative | $149.0M | $164.4M | $141.0M |
| Technical development | $39.0M | $38.7M | $33.5M |
| Total operating costs and expenses | $1.5B | $1.5B | $1.3B |
| INCOME FROM OPERATIONS | $73.9M | $68.5M | $64.5M |
| INTEREST EXPENSE, NET | -$44.5M | -$79.4M | -$93.6M |
| CHANGE IN FAIR VALUE OF WARRANTS | $55.8M | $59.5M | $0 |
| LOSS ON EXTINGUISHMENT OF DEBT | -$8.7M | $0 | $0 |
| OTHER EXPENSE, NET | -$255.0K | -$128.0K | -$65.0K |
| INCOME (LOSS) BEFORE INCOME TAX EXPENSE | $76.3M | $48.5M | -$29.1M |
| INCOME TAX EXPENSE | $14.1M | $931.0K | $5.1M |
| NET INCOME (LOSS) | $62.2M | $47.6M | -$34.1M |
| Senior Non-Convertible Preferred Stock accumulated dividends and accretion | -$73.8M | -$22.5M | $0 |
| NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS | -$11.6M | $25.0M | -$34.1M |
| Basic (in dollars per share) | -$0.06 | $0.14 | -$0.20 |
| Diluted (in dollars per share) | -$0.06 | $0.01 | -$0.20 |
| Basic (in shares) | 188.2M shares | 176.1M shares | 168.5M shares |
| Diluted (in shares) | 188.2M shares | 181.9M shares | 168.5M shares |
| Unrealized gain (loss), net of related tax benefit for the year ended June 30, 2026, and 2025, of $0.0 million,and $0.1 million, and tax expense for the year ended June 30, 2024 of $0.3 million. | $0 | -$432.0K | $1.2M |
| Net reclassification into earnings | $0 | -$3.7M | -$10.8M |
| OTHER COMPREHENSIVE LOSS | $0 | -$4.1M | -$9.6M |
| COMPREHENSIVE INCOME (LOSS) | $62.2M | $43.5M | -$43.7M |
| Other comprehensive income (loss) before reclassifications, tax | $0 | $100.0K | -$300.0K |
| Reclassification from AOCI, current period, tax | $0 | $1.3M | $3.6M |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | $20.7M | $35.7M | ||
| Accounts receivable, net of allowances of $7.1 million and $11.8 million, respectively | $166.8M | $151.4M | ||
| Commissions receivable-current | $138.7M | $132.1M | ||
| Other current assets | $24.7M | $21.8M | ||
| Total current assets | $350.9M | $341.0M | ||
| COMMISSIONS RECEIVABLENet | $852.7M | $818.8M | ||
| PROPERTY AND EQUIPMENTNet | $12.1M | $14.6M | ||
| SOFTWARENet | $18.1M | $15.1M | ||
| OPERATING LEASE RIGHT-OF-USE ASSETS | $20.5M | $24.6M | ||
| INTANGIBLE ASSETSNet | $839.0K | $2.0M | ||
| GOODWILL | $29.4M | $29.4M | ||
| OTHER ASSETS | $2.3M | $3.9M | ||
| TOTAL ASSETS | $1.3B | $1.2B | ||
| Accounts payable | $74.0M | $59.2M | ||
| Accrued expenses | $21.0M | $13.9M | ||
| Accrued compensation and benefits | $62.3M | $58.8M | ||
| Operating lease liabilitiescurrent | $4.4M | $4.8M | ||
| Current portion of long-term debt | $22.0M | $68.5M | ||
| Other current liabilities | $8.8M | $7.7M | ||
| Total current liabilities | $192.6M | $212.9M | ||
| LONG-TERM DEBT, NETless current portion | $348.2M | $316.6M | ||
| DEFERRED INCOME TAXES | $49.5M | $37.9M | ||
| OPERATING LEASE LIABILITIES | $21.8M | $26.0M | ||
| OTHER LIABILITIES | $24.8M | $80.5M | ||
| Total liabilities | $636.8M | $673.8M | ||
| Senior Non-Convertible Preferred Stock, $0.01 par value, 350,000 shares issued and outstanding as of June 30, 2026 and 2025, respectively, current liquidation preference of $423.2 million and $367.1 million as of June 30, 2026 and 2025, respectively. | $298.2M | $224.4M | ||
| Common stock, $0.01 par value700,000,000 shares authorized; 176,470,154 and 172,816,730 shares issued and outstanding as of June 30, 2026 and 2025, respectively. | $1.8M | $1.7M | ||
| Additional paid-in capital | $510.0M | $571.6M | ||
| Accumulated deficit | -$160.0M | -$222.2M | ||
| Total shareholders equity | $351.8M | $351.1M | $316.8M | $347.0M |
| TOTAL LIABILITIES, PREFERRED STOCK, AND SHAREHOLDERS EQUITY | $1.3B | $1.2B | ||
| Allowance for credit loss | $7.1M | $11.8M | ||
| Preferred stock, par value (in dollar per share) | $0.01 | $0.01 | ||
| Preferred stock, shares issued (in shares) | 350.0K shares | 350.0K shares | ||
| Preferred stock, shares outstanding (in shares) | 350.0K shares | 350.0K shares | ||
| Preferred stock, liquidation preference | $423.2M | $367.1M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 700.0M shares | 700.0M shares | ||
| Common stock, shares issued (in shares) | 176.5M shares | 172.8M shares | ||
| Common stock, shares outstanding (in shares) | 176.5M shares | 172.8M shares |
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Cash, cash equivalents, and restricted cash | $20.7M | $35.7M | ||
| Accounts receivable, net of allowances of $7.1 million and $11.8 million, respectively | $166.8M | $151.4M | ||
| Commissions receivable-current | $138.7M | $132.1M | ||
| Other current assets | $24.7M | $21.8M | ||
| Total current assets | $350.9M | $341.0M | ||
| COMMISSIONS RECEIVABLENet | $852.7M | $818.8M | ||
| PROPERTY AND EQUIPMENTNet | $12.1M | $14.6M | ||
| SOFTWARENet | $18.1M | $15.1M | ||
| OPERATING LEASE RIGHT-OF-USE ASSETS | $20.5M | $24.6M | ||
| INTANGIBLE ASSETSNet | $839.0K | $2.0M | ||
| GOODWILL | $29.4M | $29.4M | ||
| OTHER ASSETS | $2.3M | $3.9M | ||
| TOTAL ASSETS | $1.3B | $1.2B | ||
| Accounts payable | $74.0M | $59.2M | ||
| Accrued expenses | $21.0M | $13.9M | ||
| Accrued compensation and benefits | $62.3M | $58.8M | ||
| Operating lease liabilitiescurrent | $4.4M | $4.8M | ||
| Current portion of long-term debt | $22.0M | $68.5M | ||
| Other current liabilities | $8.8M | $7.7M | ||
| Total current liabilities | $192.6M | $212.9M | ||
| LONG-TERM DEBT, NETless current portion | $348.2M | $316.6M | ||
| DEFERRED INCOME TAXES | $49.5M | $37.9M | ||
| OPERATING LEASE LIABILITIES | $21.8M | $26.0M | ||
| OTHER LIABILITIES | $24.8M | $80.5M | ||
| Total liabilities | $636.8M | $673.8M | ||
| Senior Non-Convertible Preferred Stock, $0.01 par value, 350,000 shares issued and outstanding as of June 30, 2026 and 2025, respectively, current liquidation preference of $423.2 million and $367.1 million as of June 30, 2026 and 2025, respectively. | $298.2M | $224.4M | ||
| Common stock, $0.01 par value700,000,000 shares authorized; 176,470,154 and 172,816,730 shares issued and outstanding as of June 30, 2026 and 2025, respectively. | $1.8M | $1.7M | ||
| Additional paid-in capital | $510.0M | $571.6M | ||
| Accumulated deficit | -$160.0M | -$222.2M | ||
| Total shareholders equity | $351.8M | $351.1M | $316.8M | $347.0M |
| TOTAL LIABILITIES, PREFERRED STOCK, AND SHAREHOLDERS EQUITY | $1.3B | $1.2B | ||
| Allowance for credit loss | $7.1M | $11.8M | ||
| Preferred stock, par value (in dollar per share) | $0.01 | $0.01 | ||
| Preferred stock, shares issued (in shares) | 350.0K shares | 350.0K shares | ||
| Preferred stock, shares outstanding (in shares) | 350.0K shares | 350.0K shares | ||
| Preferred stock, liquidation preference | $423.2M | $367.1M | ||
| Common stock, par value (in dollars per share) | $0.01 | $0.01 | ||
| Common stock, shares authorized (in shares) | 700.0M shares | 700.0M shares | ||
| Common stock, shares issued (in shares) | 176.5M shares | 172.8M shares | ||
| Common stock, shares outstanding (in shares) | 176.5M shares | 172.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 3 fiscal years, latest first.2
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Net income (loss) | $62.2M | $47.6M | -$34.1M |
| Depreciation and amortization | $17.5M | $20.5M | $25.0M |
| Loss on disposal of property, equipment, and software | $0 | $240.0K | $536.0K |
| Impairment of long-lived assets | $0 | $4.2M | $0 |
| Impairment of equity-method investment | $1.0M | $0 | $0 |
| Loss on extinguishment of debt | $8.7M | $0 | $0 |
| Share-based compensation expense | $14.9M | $18.4M | $13.8M |
| Deferred income taxes | $11.6M | $1.8M | $1.2M |
| Amortization of debt issuance costs and debt discount | $4.3M | $5.2M | $6.1M |
| Write-off of debt issuance costs | $0 | $93.0K | $293.0K |
| Accrued interest payable in kind | $0 | $14.0M | $19.6M |
| Change in fair value of warrants | -$55.8M | -$59.5M | $0 |
| Non-cash lease expense | $4.1M | $3.9M | $2.3M |
| Bad debt expense | $0 | $4.2M | $0 |
| Accounts receivable, net | -$15.4M | -$5.6M | $5.2M |
| Commissions receivable | -$40.6M | -$69.5M | -$40.8M |
| Other assets | -$2.5M | -$6.3M | -$2.0M |
| Accounts payable and accrued expenses | $21.9M | $19.2M | $7.3M |
| Operating lease liabilities | -$4.6M | -$4.7M | -$4.9M |
| Other liabilities | $4.7M | -$5.5M | $15.6M |
| Net cash provided by (used in) operating activities | $31.9M | -$11.7M | $15.2M |
| Purchases of property and equipment | -$4.3M | -$2.2M | -$3.4M |
| Proceeds from sales of property and equipment | $0 | $0 | $253.0K |
| Purchases of software and capitalized software development costs | -$11.9M | -$9.1M | -$8.3M |
| Acquisition of business | $0 | $0 | -$3.4M |
| Net cash used in investing activities | -$16.1M | -$11.3M | -$14.8M |
| Proceeds from revolving credit facility | $358.0M | $166.9M | $0 |
| Payments on revolving credit facility | -$358.0M | -$166.9M | $0 |
| Net proceeds from Term Loan | $315.2M | $0 | $0 |
| Payments on Term Loans | -$316.0M | -$388.2M | -$38.9M |
| Proceeds on ABS Notes | $0 | $99.1M | $0 |
| Payments on ABS Notes | -$19.5M | -$16.6M | $0 |
| Payments on other debt | -$527.0K | -$312.0K | -$149.0K |
| Proceeds from common stock options exercised and employee stock purchase plan | $0 | $98.0K | $81.0K |
| Proceeds from issuance of Senior Non-Convertible Preferred Stock | $0 | $337.9M | $0 |
| Senior Non-Convertible Preferred Stock issuance costs | $0 | -$7.1M | $0 |
| Payments of tax withholdings related to net share settlement of equity awards | -$2.5M | -$5.0M | -$374.0K |
| Payments of debt issuance costs | -$7.7M | -$2.5M | -$1.5M |
| Net cash (used in) provided by financing activities | -$31.1M | $17.4M | -$40.9M |
| NET DECREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | -$15.4M | -$5.6M | -$40.5M |
| Interest paid, net | -$37.2M | -$60.6M | -$67.0M |
| Refund (payment) of income taxes, net | $192.0K | -$3.2M | -$594.0K |
| Capital expenditures in accounts payable and accrued expenses | $587.0K | $586.0K | $1.7M |
| Issuance of liability-classified warrants | $0 | $137.6M | $0 |
| Senior Non-Convertible Preferred Stock accretion | $17.6M | $5.5M | $0 |
| Senior Non-Convertible Preferred Stock accumulated dividends | $56.2M | $17.1M | $0 |
No quarter-by-quarter statement was filed.
Corporate structure
SelectQuote, Inc. sits at the top of its group. 13 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of SelectQuote, Inc.
- BlackRock Filed SCHEDULE 13G/A on SelectQuote, Inc., latest Jul 8, 2026 (7 filings since Oct 8, 2021)
- Morgan Stanley Filed SCHEDULE 13G/A on SelectQuote, Inc., latest Feb 13, 2026 (2 filings since Aug 5, 2025)
- ABRAMS BISON INVESTMENTS, LLC Filed SC 13G/A on SelectQuote, Inc., latest Feb 14, 2023
- VANGUARD GROUP INC Filed SC 13G/A on SelectQuote, Inc., latest Feb 9, 2023 (2 filings since Feb 10, 2022)
- Charan Jit Singh Filed SC 13G/A on SelectQuote, Inc., latest Feb 11, 2022
- BEP III LLC Filed SC 13G/A on SelectQuote, Inc., latest Jan 14, 2022
- ABRAMS BISON PARTNERS, LP Filed SC 13G on SelectQuote, Inc., latest Dec 3, 2021
- SelectQuote, Inc. Overland Park, Kansas
- Express Med Pharmaceuticals, Inc., dba SelectRx PA Subsidiary · Pennsylvania, United States
- Inside Response, LLC Subsidiary · Kansas, United States
- Population Health, Inc. Subsidiary · Delaware, United States
- SelectQuote Auto & Home Insurance Services, LLC Subsidiary · Delaware, United States
- SelectQuote Insurance Services Subsidiary · California, United States
- SelectQuote Local Insurance Services, LLC Subsidiary · Delaware, United States
- SelectQuote Ventures, Inc. Subsidiary · Delaware, United States
- SelectRx KS, LLC Subsidiary · Delaware, United States
- Simple Meds, LLC, dba SelectRx IN Subsidiary · Nebraska, United States
- SQ ABS Issuer, LLC Subsidiary · Delaware, United States
- SQ AgentCo Insurance Services II, LLC Subsidiary · Delaware, United States
- Tiburon Insurance Services, LLC Subsidiary · California, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What SelectQuote, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Computer equipment and software | $28.3M10 Jun 30, 2025 | $28.4M10 Jun 30, 2024 | −0.1% |
| Accumulated depreciation | $49.2M2 Jun 30, 2026 | $43.6M2 Jun 30, 2025 | +12.7% |
| Finance-lease assets | $1.5M2 Jun 30, 2026 | $1.6M2 Jun 30, 2025 | −4.3% |
| Operating-lease assets (leased space) | $20.5M2 Jun 30, 2026 | $24.6M2 Jun 30, 2025 | −16.7% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $16.0M2 Jun 30, 2026 | $32.4M2 Jun 30, 2025 | −50.5% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $29.4M2 Jun 30, 2026 | $29.4M2 Jun 30, 2025 | 0% |
| Intangible assets, net (excluding goodwill) | $839.0K2 Jun 30, 2026 | $2.0M2 Jun 30, 2025 | −57.5% |
| Finite-lived intangibles, gross | $5.9M2 Jun 30, 2026 | $24.6M2 Jun 30, 2025 | −76.2% |
| Accumulated amortization | $5.0M2 Jun 30, 2026 | $18.4M2 Jun 30, 2025 | −72.7% |
| Finite-lived intangibles, net | $839.0K2 Jun 30, 2026 | $2.0M2 Jun 30, 2025 | −57.5% |
Properties, in its own words
The following table sets forth the location, approximate square footage and primary use of each of the principal properties we occupied as of August 25, 2026. All of the properties listed below are leased, and we believe our properties are in good operating condition and are suitable for their primary use. As the majority of our office lease footprint now represents a hybrid in-person and remote work model, we have terminated or sub-leased our excess space, where commercially reasonable and to the extent unnecessary for future expansion.
Location · Approximate Square Footage Leased · Approximate Square Footage Subleased · Approximate Square Footage Occupied · Primary Use
The rest of Item 2
Overland Park, Kansas · 204,367 · 95,874 · 108,493 · Corporate headquarters, marketing and advertising, technical development, general and administrative, operations for all segments.
Centennial, Colorado · 45,373 · 32,309 · 13,064 · Subleased
Monaca, Pennsylvania · 22,000 · — · 22,000 · Healthcare Services segment (SelectRx) operations
Indianapolis, Indiana · 27,130 · — · 27,130 · Healthcare Services segment (SelectRx) operations
San Diego, California · 5,874 · — · 5,874 · Life segment operations
Olathe, Kansas · 54,000 · — · 54,000 · Healthcare Services segment (SelectRx) operations
Item 2 of the 10-K filed Aug 25, 2026.5
Leadership
Who has led SelectQuote, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
2025
- Chief executive officerTimothy Robert Danker May 20, 2020 to now15
- PresidentJoshua Brandon Matthews Aug 18, 2023 to now16
- Chief financial officerRyan Moore Clement Mar 2, 2023 to now17
- Chief financial officerRaffaele Sadun May 20, 2020 to Aug 31, 202118
Board members and other officers (18)
- OfficerSarah Taylor Anderson Aug 18, 2023 to now19
- OfficerRyan Moore Clement Jun 10, 2022 to Aug 3, 202220
- Chief Accounting OfficerStephanie D. Fisher Jun 10, 2022 to now21
- OfficerRyan Souan Mar 12, 2021 to now22
- Chief Human Resources OfficerKristin Gibbar Dec 9, 2021 to Aug 3, 202223
- CHIEF INFORMATION OFFICERFloyd O'Lander May Iii. May 20, 2020 to Aug 3, 202324
- OfficerMatthew Scott Gunter May 20, 2020 to Aug 3, 202325
- OfficerPaul L. Gregory May 20, 2020 to Aug 4, 202126
- Board memberChris Wolfe Mar 4, 2025 to now27
- Board memberSrdjan Vukovic Mar 4, 2025 to now28
- Board memberDenise L. Devine May 20, 2020 to now29
- Board memberDonald L. Hawks Iii. May 20, 2020 to now30
- Board memberEarl H. Devanny Iii. May 20, 2020 to now31
- Board memberRaymond F. Weldon May 20, 2020 to now32
- Board memberTimothy Robert Danker May 20, 2020 to now15
- Board memberW. Thomas Grant Ii. May 20, 2020 to Nov 14, 202433
- Board memberKavita Patel Sep 29, 2020 to now34
- General counselDaniel Allen Boulware May 20, 2020 to now35
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- Express Med Pharmaceuticals, Inc., dba SelectRx PA Pennsylvania4
- Inside Response, LLC Kansas4
- Population Health, Inc. Delaware4
- SQ ABS Issuer, LLC Delaware4
- SQ AgentCo Insurance Services II, LLC Delaware4
- SelectQuote Auto & Home Insurance Services, LLC Delaware4
- SelectQuote Insurance Services California4
- SelectQuote Local Insurance Services, LLC Delaware4
- SelectQuote Ventures, Inc. Delaware4
- SelectRx KS, LLC Delaware4
- Simple Meds, LLC, dba SelectRx IN Nebraska4
- Tiburon Insurance Services, LLC California4
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Timeline
- Aug 25, 20268-K Results of operations36
- May 5, 20268-K Results of operations37
- Mar 25, 20268-K Listing notice or transfer; Regulation FD disclosure38
- Feb 5, 20268-K Results of operations39
- Jan 12, 20268-K Entered a material agreement; Ended a material agreement; New debt or obligation40
- Nov 14, 20258-K Shareholder vote41
- Nov 6, 20258-K Results of operations42
- Aug 21, 20258-K Results of operations43
- Aug 21, 20258-K Results of operations44
- Jul 29, 20258-K Entered a material agreement; New debt or obligation45
- Jul 2, 20258-K Other events46
- May 12, 20258-K Results of operations47
- May 20, 2020New chief executive Timothy Robert Danker becomes CEO15
Calendar
Coming up
- Nov 4, 2026 · Before the openReports results for the quarter ending Sep/2026 A year earlier it reported ($0.26) a share, on Nov 6, 2025.48
When it reported results
- Aug 25, 2026Reported quarterly or annual results36
- May 5, 2026Reported quarterly or annual results37
- Feb 5, 2026Reported quarterly or annual results39
- Nov 6, 2025Reported quarterly or annual results42
- Aug 21, 2025Reported quarterly or annual results43
- Aug 21, 2025Reported quarterly or annual results44
- May 12, 2025Reported quarterly or annual results47
- Feb 10, 2025Reported quarterly or annual results49
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
251 filings to the SEC since October 2021: 6 annual reports, 16 quarterly reports, 44 major events, 147 insider forms, 15 large holders, 23 other. The latest 20:
- Sep 30, 2026DEFA14A EDGAR
- Sep 30, 2026DEF 14A EDGAR
- Sep 18, 2026PRE 14A EDGAR
- Aug 25, 202610-K EDGAR
- Aug 25, 20268-K EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Aug 4, 20264 EDGAR
- Jul 8, 2026SCHEDULE 13G/A EDGAR
- May 21, 20264 EDGAR
- May 19, 2026144 EDGAR
- May 5, 202610-Q EDGAR
- May 5, 20268-K EDGAR
- Mar 25, 20268-K EDGAR
- Mar 3, 20264 EDGAR
The 251 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
14 open-market trades by officers, directors and large owners since October 2021: 12 buys and 2 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 19, 2026 | Devine Denise LDirector | Sale | 4,000 | $1.02 | $4.1K | Form 4 |
| Feb 11, 2026 | Grant Robert ClayPRESIDENT | Buy | 118,901 | $0.89 | $105.4K | Form 4 |
| Mar 14, 2025 | Devine Denise LDirector | Buy | 4,000 | $3.62 | $14.5K | Form 4 |
| Feb 20, 2025 | Anderson Sarah Taylor(See Remarks) | Sale | 50,000 | $5.44 | $272.0K | Form 4 |
| Sep 18, 2023 | Matthews Joshua BrandonPresident, SelectQuote Senior | Buy | 97,500 | $1.16 | $113.1K | Form 4 |
| Sep 15, 2023 | Grant William Thomas IIICHIEF OPERATING OFFICER | Buy | 150,000 | $1.20 | $180.0K | Form 4 |
| Sep 15, 2023 | GRANT W THOMAS IIDirector | Buy | 220,100 | $1.17 | $257.5K | Form 4 |
| Sep 15, 2023 | Grant Robert ClayPRESIDENT | Buy | 184,200 | $1.14 | $210.0K | Form 4 |
| May 16, 2023 | GRANT W THOMAS IIDirector | Buy | 425,000 | $1.28 | $544.0K | Form 4 |
| May 16, 2023 | Weldon Raymond FDirector | Buy | 100,000 | $1.20 | $120.0K | Form 4 |
| May 16, 2023 | Hawks Donald L IIIDirector | Buy | 100,000 | $1.16 | $116.0K | Form 4 |
| May 16, 2023 | Grant Robert ClayPRESIDENT | Buy | 200,000 | $1.28 | $256.0K | Form 4 |
| May 16, 2023 | Danker Timothy RobertCHIEF EXECUTIVE OFFICER | Buy | 100,000 | $1.23 | $123.0K | Form 4 |
| Sep 2, 2022 | Gunter Matthew ScottChief Experience Officer | Buy | 24,300 | $1.04 | $25.3K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- BlackRockSCHEDULE 13G/A, 7 filings Oct 8, 2021 to Jul 8, 202650
- Morgan StanleySCHEDULE 13G/A, 2 filings Aug 5, 2025 to Feb 13, 202651
- ABRAMS BISON INVESTMENTS, LLCSC 13G/A, 1 filing Feb 14, 202352
- VANGUARD GROUP INCSC 13G/A, 2 filings Feb 10, 2022 to Feb 9, 202353
- Charan Jit SinghSC 13G/A, 1 filing Feb 11, 202254
- BEP III LLCSC 13G/A, 1 filing Jan 14, 202255
- ABRAMS BISON PARTNERS, LPSC 13G, 1 filing Dec 3, 202156
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Abrams Bison Investments, LLC | 7,910,794 | $6.7M | 0.3% | No change |
| Mariner, LLC | 6,553,063 | $5.5M | 0.0% | +66,398 |
| Vanguard Capital Management LLC | 6,110,257 | $5.1M | 0.0% | +121,095 |
| Aqr Capital Management LLC | 2,468,729 | $2.1M | 0.0% | +1,316,104 |
| Captrust Financial Advisors | 2,354,276 | $2.0M | 0.0% | +67,050 |
| BlackRock, Inc. | 2,182,553 | $1.8M | 0.0% | −8,530,867 |
| Qube Research & Technologies Ltd | 2,148,653 | $1.8M | 0.0% | New |
| Jane Street Group, LLC | 2,132,688 | $1.8M | 0.0% | New |
| Diametric Capital, LP | 1,969,167 | $1.7M | 0.2% | +18,078 |
| Geode Capital Management, LLC | 1,746,671 | $1.5M | 0.0% | −1,737,736 |
| Millennium Management LLC | 1,649,948 | $1.4M | 0.0% | New |
| Guggenheim Capital LLC | 1,199,960 | $1.0M | 0.0% | −1,250 |
| Goldman Sachs Group Inc | 1,176,775 | $989.8K | 0.0% | −44,742 |
| Tudor Investment Corp Et Al | 1,124,580 | $945.9K | 0.0% | +143,301 |
| TriaGen Wealth Management LLC | 1,055,500 | $887.8K | 0.2% | No change |
| Jacobs Levy Equity Management, Inc | 1,006,148 | $846.3K | 0.0% | +135,461 |
| Truffle Hound Capital, LLC | 1,000,000 | $841.1K | 0.5% | New |
| Vanguard Fiduciary Trust Co | 937,604 | $788.5K | 0.0% | −39,721 |
| Renaissance Technologies LLC | 823,271 | $692.5K | 0.0% | −197,968 |
| Fmr LLC | 812,648 | $683.5K | 0.0% | +15,742 |
| Charles Schwab Investment Management Inc | 803,155 | $675.5K | 0.0% | −192,942 |
| Creative Planning | 742,044 | $624.1K | 0.0% | +150,455 |
| State Street Corp | 708,917 | $596.3K | 0.0% | −2,284,421 |
| Dimensional Fund Advisors LP | 702,327 | $589.9K | 0.0% | −820,395 |
| Squarepoint Ops LLC | 637,242 | $536.0K | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
SEC filer profile
How SelectQuote, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSelectQuote, Inc.1
- CIK0001794783
- Employer ID (EIN)94-33392735
- Filer statusAccelerated filer not an emerging growth company; a smaller reporting company; not a shell company5
- Incorporated inDelaware5
- Fiscal year endsJune 301
- Industry code (SIC)6411 Insurance Agents, Brokers & Service1
- SEC reviewing officeOffice of Finance, Division of Corporation Finance1
- Business address6800 West 115Th Street, Suite 2511, Overland Park, KS 662111
- Phone91327419941
- Shares outstanding176,573,132 shares as of Jul 31, 20265
- Public float$198.8M as of Dec 31, 20255
- AuditorDeloitte & Touche LLP, Kansas City, Missouri PCAOB ID 34; it also attests to the company’s internal control over financial reporting5
- On EDGAR sinceNov 27, 20191
- Filings446 in all: 4 (253), 8-K (60), 3 (27), 10-Q (18), SC 13G/A (11), DEF 14A (8), DEFA14A (8), 10-K (7)1
All 32 form types
SC 13G (6), CORRESP (5), S-8 (5), S-1/A (4), UPLOAD (4), 8-K/A (3), 144 (2), 5 (2), DRS (2), DRS/A (2), DRSLTR (2), EFFECT (2), PRE 14A (2), S-1 (2), SCHEDULE 13G/A (2), 10-K/A (1), 10-Q/A (1), 424B1 (1), 424B4 (1), 8-A12B (1), CERT (1), NT 10-Q (1), S-1MEF (1), SCHEDULE 13G (1)
- Latest filingsAnnual report (10-K) Aug 25, 2026
Quarterly report (10-Q) May 5, 2026
Proxy statement (DEF 14A) Sep 30, 2026
Latest 8-K (8-K) Aug 25, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.01 per share | SLQT | New York Stock Exchange |
From the cover page of the 10-K filed Aug 25, 2026 (Section 12(b) of the Exchange Act).5
Risk factors and legal proceedings
The risks SelectQuote, Inc. names in Item 1A of its 10-K filed Aug 25, 2026: 55 risks under these headings, as written.5
- Risks Related to Our Business and Industry
- Risks Related to Our Intellectual Property and Our Technology
- Risks Related to Laws and Regulation
- General Risk Factors
- Our business may be harmed if we lose our relationships with our insurance carrier partners or fail to develop new insurance carrier relationships.
- We currently depend on a small group of insurance carrier partners and their affiliates for a substantial portion of our business. If we become even more dependent on a limited number of insurance carrier partners, our business and financial condition may be adversely affected.
- Changes in the health insurance market or in the variety, quality and affordability of the insurance products offered by our insurance carrier partners could harm our business, operating results, financial condition and prospects.
- Our insurance carrier partners could determine to reduce the commissions paid to us and change their underwriting practices in ways that reduce the number of, or impact the renewal or approval rates of, insurance policies sold through our distribution platform, which could harm our business, operating results, financial condition and prospects.
- Insurance carriers can offer products and services directly to consumers or through our competitors.
- Pressure from existing and new competitors may adversely affect our business and operating results, financial condition and prospects.
- Our business is substantially dependent on revenue from our Senior health insurance carrier partners and is subject to risks related to Senior health insurance and the larger health insurance industry. Our business may also be adversely affected by downturns in the life insurance industry.
- Systemic changes in our insurance carrier partners’ sales strategies could adversely affect our business.
The other 47 risks
- If we are unable to develop new offerings, achieve increased consumer adoption of those offerings or penetrate new vertical markets, our business, operating results, financial condition and prospects could be materially and adversely affected.
- Risks from third-party products could adversely affect our businesses.
- If our ability to enroll individuals during AEP and OEP is impeded, our business will be harmed.
- If we are unable to attract, integrate and retain qualified personnel, our ability to develop and successfully grow our business could be harmed.
- Our business is dependent on our obtaining a large quantity of quality insurance sales leads in a cost-effective manner.
- Our business depends on our ability to convert sales leads to actual sales of insurance policies. If our conversion rate does not meet expectations, our business may be adversely affected.
- We rely on data provided to us by consumers and our insurance carrier partners to improve our technology and service offerings, and if we are unable to maintain or grow such data, we may be unable to provide consumers with an insurance shopping experience that is relevant, efficient and effective, which could adversely affect our business.
- Our ability to match consumers to insurance products that suit their needs is dependent upon their provision of accurate information during the insurance shopping process.
- We depend upon internet search engines to attract a significant portion of the consumers who visit our website, and if we are unable to effectively advertise on search engines on a cost-effective basis our business, operating results, financial condition and prospects could be harmed.
- Our business could be harmed if we are unable to contact consumers or market the availability of our products by telephone.
- Global economic conditions that affect the financial stability of our insurance carrier partners, vendors, and consumers could, in turn, materially and adversely affect our revenue and results of operations.
- If we are unable to attract new pharmacy customers and retain and grow our relationships with existing pharmacy customers, our business, results of operations, financial condition, and future prospects may be materially and adversely affected.
- We face risks relating to the availability, pricing and safety profiles of prescription medications that we purchase and sell.
- Changes in third-party reimbursement levels for prescription drugs and changes in industry pricing benchmarks could reduce our pharmacy margins and have a material adverse effect on our business.
- We may be subject to significant liability should the consumption of any of the products offered through our pharmacy business cause injury, illness, or death.
- We may acquire other companies or technologies, which could divert our management’s attention, result in additional dilution to our stockholders and otherwise disrupt our operations and harm our operating results, financial condition and prospects.
- Impairment of the carrying value of our goodwill or other intangible assets could adversely affect our financial condition and results of operations.
- Our existing and any future indebtedness could adversely affect our ability to operate our business.
- Operating and growing our business may require additional capital, and if capital is not available to us, our business, operating results, financial condition and prospects may suffer.
- If we fail to protect our brand, our ability to expand the use of our agency services by consumers may be adversely affected.
- Seasonality may cause fluctuations in our financial results.
- We rely on our insurance carrier partners to prepare accurate commission reports and send them to us in a timely manner.
- Our operating results fluctuate depending upon the timing of insurance carrier payments, data and policy approval practices from our insurance carrier partners.
- Our operating results will be impacted by factors that impact our estimate of the lifetime value of commissions per policyholder.
- If we are unable to adequately protect our intellectual property, our ability to compete could be harmed.
- We may become subject to intellectual property disputes, which are costly and may subject us to significant liability and increased costs of doing business.
- Our business depends on our ability to maintain and improve the technological infrastructure that supports our distribution platform, and any significant disruption in service on our platform could result in a loss of consumers, which could harm our business, brand, operating results, financial condition and prospects.
- Potential changes in applicable technology and consumer outreach techniques could have a material and adverse effect on our operating results, financial condition and prospects.
- We rely on third-party service providers that provide the infrastructure for our technological systems, and any failure to maintain these relationships could harm our business.
- Our business could be materially and adversely affected by a cybersecurity breach or other attack involving our computer systems or those of our insurance carrier partners or third-party service providers.
- We collect, process, store, share, disclose and use consumer information and other data, and an actual or perceived failure to protect such information and data or respect users’ privacy could damage our reputation and brand and harm our business, operating results, financial condition and prospects.
- Issues related to the development and use of artificial intelligence (AI) could give rise to legal and regulatory action, damage our reputation, or otherwise materially harm of our business.
- Laws and regulations regulating insurance activities are complex and could have a material and adverse effect on our business, reduce our profitability, and potentially limit our growth.
- Our Senior segment is subject to a complex legal and regulatory framework, and non-compliance with or changes in laws and regulations governing the marketing and sale of Medicare plans and other health-related products and services could harm our business, operating results, financial condition and prospects.
- Our business may be harmed by competition from government-run health insurance exchanges.
- Changes and developments in the regulation of the healthcare industry could adversely affect our business.
- Changes and developments in the health insurance system and laws and regulations governing the health insurance markets in the United States could materially and adversely affect our business, operating results, financial condition and prospects.
- Our business may be harmed if our website and marketing materials are not timely approved or do not comply with legal requirements.
- Our healthcare services operations, including our pharmacy business, face regulatory and operational risks and uncertainties that differ from the risks of our other businesses.
- We may not be able to maintain compliance with all current and potentially applicable U.S. federal and state or foreign laws and regulations, and actions by regulatory authorities or changes in legislation and regulation in the jurisdictions in which we operate could have a material adverse effect on our business.
- If we are unable to regain compliance with the continued listing standards of the New York Stock Exchange (the “NYSE”), the NYSE may delist our common stock, which could have an adverse impact on the liquidity, trading volume, and market value of our common stock.
- From time to time we are subject to various legal proceedings that could adversely affect our business.
- Our communications with potential and existing customers are subject to laws regulating telephone and email marketing practices.
- Any legal liability for the information we communicate to consumers could harm our business and operating results.
- Our quarterly and annual operating results or other operating metrics may fluctuate significantly and may not meet expectations of research analysts, which could cause the trading price of our common stock to decline.
- We are required to make significant estimates and assumptions in the preparation of our financial statements. These estimates and assumptions may not be accurate and are subject to change.
- We do not intend to pay dividends in the foreseeable future.
Legal proceedings
From time to time we are a party to various litigation matters incidental to the conduct of our business. These legal matters primarily involve claims for damages arising out of the use of the Company’s services, insurance regulatory claims, and claims relating to intellectual property matters, employment matters, tax matters, commercial disputes, competition and sales practices. The Company may also become subject to lawsuits as a result of past or future acquisitions or as a result of liabilities retained from, or representations, warranties or indemnities provided in connection with, divested businesses. We are not presently party to any legal proceedings the resolution of which we believe would have a material adverse effect on our business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels. However, in the event of unexpected further developments, it is possible that the ultimate resolution of these matters, or other similar matters, if unfavorable, may be materially adverse to our business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels. For additional details, see Part II, Item 8, Note 11, Commitments and Contingencies – “Legal Contingencies and Obligations,” in the notes to consolidated financial statements in Item 8 of this Annual Report on Form 10-K, which is incorporated herein by reference.
The opening of Item 3, Legal Proceedings.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16SEC EDGARJoshua Brandon Matthews, President
- 17
- 18
- 19SEC EDGARSarah Taylor Anderson, Officer
- 20SEC EDGARRyan Moore Clement, Officer
- 21
- 22SEC EDGARRyan Souan, Officer
- 23
- 24
- 25SEC EDGARMatthew Scott Gunter, Officer
- 26SEC EDGARPaul L. Gregory, Officer
- 27SEC EDGARChris Wolfe, Board member
- 28SEC EDGARSrdjan Vukovic, Board member
- 29SEC EDGARDenise L. Devine, Board member
- 30SEC EDGARDonald L. Hawks Iii., Board member
- 31SEC EDGAREarl H. Devanny Iii., Board member
- 32SEC EDGARRaymond F. Weldon, Board member
- 33SEC EDGARW. Thomas Grant Ii., Board member
- 34SEC EDGARKavita Patel, Board member
- 35
- 36SEC EDGARResults of operations
- 37SEC EDGARResults of operations
- 38
- 39SEC EDGARResults of operations
- 40
- 41SEC EDGARShareholder vote
- 42SEC EDGARResults of operations
- 43SEC EDGARResults of operations
- 44SEC EDGARResults of operations
- 45
- 46SEC EDGAROther events
- 47SEC EDGARResults of operations
- 48NasdaqNasdaq calendar
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57